Cullinan Therapeutics, Inc. (NASDAQ: CGEM) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CULLINAN THERAPEUTICS, INC.

Cullinan Therapeutics, Inc. (NASDAQ: CGEM)
Listen to this Section


$13.96
-0.4700 ( -3.26% ) 345.2K

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

Market Data


Open $13.96
Previous Close $14.43
Volume 345.2K
Market Cap $934.78M
Day Range $13.91 - $15.65
52 Week Range $5.68 - $16.74
Shares Outstanding 61.46M
Change % -3.26%
Net Change ▼ -0.4700
Insider Ownership -0.01%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -250,082.00

Date Type Amount Purchased Purchaser
2025-10-30 Buy 165667.00 Lynx1 Capital Management LP
2025-10-21 Buy 15032.00 Lynx1 Capital Management LP
2025-10-10 Buy 556300.00 Lynx1 Capital Management LP
2024-08-09 Sale -25743.00 Thistle Mary
2024-07-09 Sale -8000.00 Michaelson Jennifer
2024-07-02 Sale -2360.00 Michaelson Jennifer
2024-06-27 Sale -15806.00 Rosenberg Anthony
2024-06-27 Sale -15806.00 Martin Anne-Marie
2024-06-27 Sale -15806.00 Webster Stephen W
2024-06-27 Sale -15806.00 Ryan David P.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Aug 08, 2025
3 Insider transactions 2 Aug 08, 2025
8-k 8K-related 11 Aug 07, 2025
10-q Quarterly Reports 62 Aug 07, 2025
4 Insider transactions 1 Jun 16, 2025
4 Insider transactions 1 Jun 16, 2025
4 Insider transactions 1 Jun 16, 2025
4 Insider transactions 1 Jun 16, 2025
4 Insider transactions 1 Jun 16, 2025
8-k 8K-related 10 Jun 12, 2025

Latest News


× Before browsing our site, please accept our cookies policy